WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy

Not Applicable

Completed

Conditions: Colon Cancer
Brain Cancer
Ovarian Cancer
Head and Neck Cancer
Lung Cancer
Gastric Cancer

Interventions: Device: Halcyon 4.0 system

First Posted Date: 2022-06-22

Last Posted Date: 2024-10-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 55

Registration Number: NCT05427214

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

COVID-19 Vaccine Uptake Trial

Not Applicable

Completed

Conditions: COVID-19
Vaccination Refusal

Interventions: Other: Short Message Service (SMS) + Website Link Strategy
Other: Phone Call with Peer Strategy

First Posted Date: 2022-06-15

Last Posted Date: 2025-04-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 262

Registration Number: NCT05419232

Locations: 🇺🇸
Ferguson-Florissant School District, Hazelwood, Missouri, United States
🇺🇸
Jennings School District, Jennings, Missouri, United States
🇺🇸
St. Louis Language Immersion School, Saint Louis, Missouri, United States

and more 5 locations

Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma

Phase 1

Recruiting

Conditions: Transformed Lymphoma
Aggressive Lymphoma
B Cell Lymphoma
Diffuse Large B Cell Lymphoma
High-grade B-cell Lymphoma
Follicular Lymphoma Grade 3

Interventions: Drug: Mosunetuzumab

First Posted Date: 2022-06-09

Last Posted Date: 2025-04-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT05412290

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic Leukemia

Not Applicable

Terminated

Conditions: Acute Lymphoblastic Leukemia

Interventions: Behavioral: Family-based Behavioral Weight Loss Treatment

First Posted Date: 2022-06-08

Last Posted Date: 2024-05-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 17

Registration Number: NCT05410574

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma

Phase 2

Active, not recruiting

Conditions: Lymphoma, Follicular
Follicular Lymphoma

Interventions: Drug: Mosunetuzumab
Drug: Polatuzumab vedotin

First Posted Date: 2022-06-08

Last Posted Date: 2025-04-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 34

Registration Number: NCT05410418

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas

Not Applicable

Recruiting

Conditions: Glioma, Malignant
Astrocytoma
Oligodendroglioma, Adult

Interventions: Radiation: temporally-modulated pulsed radiotherapy (TMPRT)

First Posted Date: 2022-05-26

Last Posted Date: 2025-04-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 12

Registration Number: NCT05393258

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct

Not Applicable

Recruiting

Conditions: Acute Ischemic Stroke

Interventions: Device: Sham transcutaneous vagal nerve stimulation
Device: transcutaneous auricular vagal nerve stimulation

First Posted Date: 2022-05-25

Last Posted Date: 2023-12-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 80

Registration Number: NCT05390580

Locations: 🇺🇸
Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States

Improving Health and Employment Outcomes Through Workplace Opioid Policies

Not Applicable

Completed

Conditions: Opioid-Related Disorders

Interventions: Behavioral: Best Practice Health and Employment Opioid-related Policies

First Posted Date: 2022-05-24

Last Posted Date: 2024-10-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 4939

Registration Number: NCT05387408

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies

Phase 1

Active, not recruiting

Conditions: Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
Anaplastic Large Cell Lymphoma
T-Cell Non-Hodgkin Lymphoma
Acute Myeloid Leukemia
T Cell Prolymphocytic Leukemia
Extranodal NK/T-cell Lymphoma
Angioimmunoblastic T-cell Lymphoma
Enteropathy-Associated T-Cell Lymphoma
Adult T Cell Lymphoma
Sezary Syndrome

Interventions: Biological: WU-CART-007

First Posted Date: 2022-05-17

Last Posted Date: 2025-04-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 6

Registration Number: NCT05377827

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Suubi4StrongerFamilies

Not Applicable

Recruiting

Conditions: Child Behavioral Health

Interventions: Behavioral: EE plus MFG-based FS
Behavioral: Economic Empowerment (EE)
Behavioral: Multiple Family Group based Family Strengthening (MFG-based FS)

First Posted Date: 2022-05-10

Last Posted Date: 2024-11-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 968

Registration Number: NCT05368714

Locations: 🇺🇬
International Center for Child Health and Development, Masaka, Uganda

Home Terms & Conditions Privacy Policy